Here's why BHP Billiton Limited has taken a 2.2% dive today

BHP Billiton Limited (ASX:BHP) shares were smashed following some more bad news for shareholders.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of BHP Billiton Limited (ASX: BHP) have lost a further 74 cents or 2.2% of their value today, compared to a 0.7% decline by the benchmark S&P/ASX 200 Index (Index: ^AXJO) (ASX: XJO). The heavy decline came after the miner scrapped its plans to sell its Nickel West business, saying that a buyer hadn't come forward with an acceptable bid for the assets.

So What: The Nickel West business is not considered a core asset by BHP Billiton which instead wants to focus on its four pillar strategy going forward. This includes its iron ore, copper, coal and petroleum operations, with a possible addition of potash in the coming years.

In May, BHP Billiton stated that it was reviewing its options for the Nickel West business, hoping to take advantage of the strengthening nickel prices to offload it at a decent price. The miner had been hoping to sell it separate to other non-core assets and thus excluded it from its proposed spin-off which it hopes will proceed at some point in 2015.

As reported in The Australian Financial Review, Glencore and Chinese nickel major Jinchuan are believed to have tabled bids for the business, but both were considered far too low for BHP which had been hoping to maximise the value for shareholders. The business will unofficially remain up for sale and will not be bundled into the proposed demerger, currently known as 'NewCo'.

Now What: The failure to sell Nickel West is clearly a setback for BHP Billiton. Not only could the proceeds have been put towards paying down debt or improving shareholder returns, the miner is now also stuck with an environmental rehab bill estimated to be worth up to US$2 billion that is attached to the Nickel West business.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »